FTC sues key pharmacy profit managers above insulin selling prices The company brought motion versus Caremark, Convey Scripts and Optum Rx, arguing their “anticompetitive and unfair” rebating methods “artificially inflated” the listing price of everyday living-conserving insulin medicine. Elevance lowers guidance on ‘unprecedented’ Medicaid problems Executives explained the improved c... https://beaundtkz.bloggadores.com/30095469/healthcare-news-things-to-know-before-you-buy